NLRP3 inflammasome activation could promote CSCs formation, and NLRP3 inflammasome blockade could reduce CSCs formation in SCCHN cell lines and Tgfbr1/Pten 2cKO mouse SCCHN model. The gene discussed is TGFBR1; the disease is head and neck squamous cell carcinoma.